Here, we validated the increase in PABPC1 levels in bladder cancer cell lines and found that PABPC1 expression was suppressed after PD but recovered after treatment with miR-129-5p inhibitor. This evidence concerns the gene PABPC1 and urinary bladder carcinoma.